OFFICIAL PUBLICATION OF

by its subsidiary APPco

EpiPen 300µg recall

Megan Haggan 20/03/2017

Alphapharm is recalling several batches of EpiPen 300µg, with an expiry date of April 17 Following consultation with the TGA, Alphapharm has initiated a recall of four batches of its EpiPen 300 microgram (µg) Adrenaline Injection Syringe Auto-Injectors. This is due to the potential that these devices may contain a defective part that may result in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Patients back scope expansion

fully agree

Benjamyn Sung

Patients back scope expansion

The benefits of qualitative research is not something taught to pharmacists. Even across 100 participants there would be common themes…

Ben Wishaw

Patients back scope expansion

I get that the requirements might be different but if we do a simple gut-check, surveying 100 people really can't…

John Smith

Ozempic shortage to continue in 2025

Appalled at this given the flooding of Wegovy at the wholesalers the past several months. Add to that the wasted…

Greg Willday

EpiPen 300µg recall

Previous Low FODMAP diet helps in IBS, endometriosis

Next New vitamin D indication suggested - and challenged

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Low FODMAP diet helps in IBS, endometriosis

Next New vitamin D indication suggested - and challenged

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.